Stay updated on ZFN Therapeutic SB-318 in MPS I Clinical Trial
Sign up to get notified when there's something new on the ZFN Therapeutic SB-318 in MPS I Clinical Trial page.

Latest updates to the ZFN Therapeutic SB-318 in MPS I Clinical Trial page
- Check2 days agoChange DetectedAdded the MeSH term Mucopolysaccharidosis, MPS-I-H/S and an external resource link to the Genetic and Rare Diseases Information Center on the study page.SummaryDifference0.2%

- Check9 days agoChange DetectedHurler-Scheie syndrome and the Genetic and Rare Diseases Information Center resource were removed, reducing disease-specific context and external reference points for the study.SummaryDifference0.2%

- Check17 days agoChange DetectedSite revision updated from v3.4.3 to v3.5.0, indicating a frontend version upgrade without changes to the study details or eligibility.SummaryDifference0.1%

- Check24 days agoChange DetectedThe page now displays Revision: v3.4.3, replacing the previous Revision: v3.4.2.SummaryDifference0.1%

- Check52 days agoChange DetectedThe page now displays Revision: v3.4.2, and the prior government-funding lapse notice (along with the v3.4.1 revision) has been removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check59 days agoChange DetectedAdministrative updates were added: a site-wide notice about a lapse in government funding and a revision to v3.4.1 replacing v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to ZFN Therapeutic SB-318 in MPS I Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ZFN Therapeutic SB-318 in MPS I Clinical Trial page.